Krystal Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	10,784	7,197	4,511	3,503	2,041	1,763
Market Cap Growth	161.87%	59.55%	28.77%	71.63%	15.75%	49.07%
Enterprise Value	9,776	6,379	3,921	2,979	1,671	1,333
Last Close Price	365.81	246.54	156.66	124.06	79.22	69.95
PE Ratio	48.99	36.04	52.22	318.10	-	-
Forward PE	42.64	34.89	33.31	-	-	-
PS Ratio	25.84	18.50	15.53	69.09	-	-
PB Ratio	8.43	5.90	4.77	4.50	3.91	2.97
P/TBV Ratio	8.62	6.06	4.92	4.42	3.87	2.62
P/FCF Ratio	45.43	38.10	37.85	-	-	-
P/OCF Ratio	43.09	35.83	36.55	-	-	-
EV/Sales Ratio	23.43	16.39	13.50	58.76	-	-
EV/EBITDA Ratio	54.17	38.00	54.11	-	-	-
EV/EBIT Ratio	54.70	39.55	59.63	-	-	-
EV/FCF Ratio	41.18	33.76	32.90	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.05	0.06	0.10	-	-	-
Debt / FCF Ratio	0.04	0.05	0.06	-	-	-
Net Debt / Equity Ratio	-0.64	-0.67	-0.62	-0.67	-0.71	-0.72
Net Debt / EBITDA Ratio	-4.39	-4.88	-8.15	5.05	2.61	6.57
Net Debt / FCF Ratio	-3.43	-4.33	-4.95	5.21	2.41	3.70
Asset Turnover	0.31	0.33	0.31	0.07	0	0
Inventory Turnover	0.59	0.69	1.20	0.89	-	-
Quick Ratio	8.82	9.28	6.89	17.35	13.14	17.02
Current Ratio	9.46	9.95	7.28	17.76	13.30	17.18
Return on Equity (ROE)	18.03%	18.91%	10.34%	1.68%	-25.09%	-15.71%
Return on Assets (ROA)	14.20%	14.59%	6.56%	-13.50%	-24.51%	-14.57%
Return on Invested Capital (ROIC)	44.91%	46.05%	20.13%	-45.71%	-92.04%	-69.71%
Return on Capital Employed (ROCE)	14.18%	14.77%	7.56%	-16.67%	-25.69%	-15.24%
Earnings Yield	2.09%	2.77%	1.91%	0.31%	-	-
FCF Yield	2.20%	2.62%	2.64%	-	-	-
Buyback Yield / Dilution	-0.75%	-0.71%	-7.16%	-8.87%	-14.85%	-18.15%
Total Shareholder Return	-0.75%	-0.71%	-7.16%	-8.87%	-14.85%	-18.15%

SEC Filings: 10-K · 10-Q